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In summary, the main developments over the last few decades
have been in the change in basic concepts concerning the
pathophysiology of the disease, which have moved from a fairly
mechanical hypothesis to include a number of interactive path-
ways explaining the global structural changes in joint tissues.
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FEMORO-ACCETABULAR IMPINGEMENT: FREQUENT
INITIATOR OF OSTEOARTHRITIS OF THE HIP
Reinhold Ganz
We describe a mechanism for osteoarthritis of the non-dysplastic
hip in which the degenerative process is initiated by impingement
between the proximal end of the femur and the acetabular rim
rather than by axial overload within the joint. Relatively minor
abnormal anatomical orientation and morphology of the acetab-
ulum and the proximal end of the femur could be identified as to
reduce the clearance for motion and to lead to impingement of
the well constraint ball and socket joint. Most frequent place of
impingement is the anterio-superior joint area and most critical
motion is flexion-internal rotation.
As acetabular causes for impingement local or general overcover
due to acetabular retroversion or a deep socket could be verified,
both conditions known to contribute to chronic hip problems. As
femoral causes a head with a non-spherical periphery, malaligne-
ment between head and neck, reduced anteversion of the neck
and a low cervico-diaphyseal angle have been identified. Pistol
grip deformity and retrotilt of the femoral head being part in
this list are known as to be associated with early osteoarthri-
tis. Excessive demand on hip motion seems to accelerate the
destruction as well as velocity and force of its critical excursion.
With surgical dislocation of the hip joint new insights of the
pathogenetic process were possible allowing to reproduce im-
pingement as the damaging cause, Two types of impingement
could be distinguished differing in the injury pattern at the ac-
etabular rim: The cam impingement is caused by the femoral
end, where its pathomorphology with an increasing radius is
jammed into the acetabulum during forceful motion. The result-
ing shear forces produce abrasion of the acetabular cartilage
and its outside-in avulsion from labrum and subchondral bone
in a rather constant antero-superior area, while the cartilage of
the femoral head, in its spherical part, remains normal. Later in
the disease mechanical overload and chronic irritation may con-
tribute to the joint deterioration. The degeneration of the labrum
is secondary to the disconnection from the cartilage. The pincer
impingement produces a more linear impact between a local or
general overcover of the acetabulum and the femoral head-neck
junction. With this type, the first structure to fail is the acetabular
labrum. Damage to the acetabular cartilage is first limited to a
small strip near the labrum. Later and as a result of the chronic
leverage, damage to posterior-inferior joint cartilage becomes
apparent. Again the cartilage of the spherical head in its superior
surface remains normal over a long period. Acetabular cartilage
damage from pincer impingement seems to develop slower and
is less extensive than with the cam impingement, however most
hips show a mixed cam- and pincer-impingement.
Based on the observation of about 2000 hips we speculate
that the pathogenesis of most primary and secondary types of
osteoarthritis is best explained by the impingement concept.
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IS SURFACE REPLACEMENT AN ALTERNATIVE TO
CONVENTIONAL THR?
Peter Grigoris
Total hip replacement (THR) is a successful reconstructive pro-
cedure for patients with arthritis. Despite the excellent results in
older patients, the outcome in the active patient younger than 55
years is generally poor as reported by various national arthro-
plasty registries [1]. The principal cause of failure is wear of
the articulating surfaces resulting in the production of particulate
debris which insights a localised inflammatory tissue reaction
causing bone resorption and prosthetic loosening
Metal on metal hip resurfacing is an alternative procedure to
conventional THR with a low wear producing articulation. It has
the advantage of preservation of proximal femoral bone stock at
the time of surgery and avoidance of long-term stress shielding.
Revision surgery, if required, should therefore be easier and
more durable. In addition, the large diameter of the articulation,
offers increased stability and range of movement for the active
individual [2].
The concept of hip resurfacing is not new. It has evolved di-
rectly from the original mould arthroplasty introduced by Smith
Petersen in 1948. In the early 1950s, Sir John Charnley, the
pioneer of conventional THR, experimented with hip resurfacing
using Teflon, which was a material with poor wear characteristics.
In the 1970s, cemented systems using a polyethylene acetabular
component and a metal femoral cup were introduced around
the world. The results were disappointing and the procedure
was largely abandoned by the mid 1980s. The large diameter of
the articulation combined with thin polyethylene cups or liners,
led to accelerated wear and the production of large volumes of
biologically active particulate debris leading to bone loss and
implant loosening. However, as the implications of wear debris
induced osteolysis were not fully appreciated at the time, failure
was attributed to other factors primarily avascular necrosis of the
femoral head, and femoral neck fracture. The failure of previous
generations of hip resurfacing was essentially a consequence
of the use of inappropriate materials, poor implant design and
inadequate instrumentation rather than an inherent problem with
the procedure itself.
The renaissance of metal-on-metal articulations for THR began
in 1988 when Bernard Weber developed the Metasul™ bearing
[3]. The availability of a durable low wear bearing which could
be used in a large diameter articulation enabled the introduction
of new generation of hip resurfacings in 1991. By the end
of 2004, the majority of the main implant manufacturers had
introduced metal-on-metal hip resurfacing systems. To date, only
short to medium term results are available, but these results
are much better compared to the earlier metal on polyethylene
resurfacings. The complications commonly seen in the 1970s
and 1980s, such as early implant loosening and femoral neck
fracture now appear to be rare [4,5].
Concern has been raised about the biological effects of the
elevated levels of metal ions and metal particles found in blood,
periprosthetic tissues and lympho-reticular system in all patients
with metal-on-metal bearings. However, to date, there is no
evidence that patients with metal-on-metal bearings in situ are
more likely to develop such malignancies when compared with
the general population [6].
Further work will be required to establish the prevalence of
femoral neck fractures and avascular necrosis of the remaining
femoral head. Long term observational studies and controlled
trials will be required to determine if the potential advantages
of hip resurfacing compared to conventional THR are realised.
Whilst early results should be regarded with caution, the present
generation of metal-on-metal hip resurfacings potentially offer the
ultimate bone preservation and restoration of function in appro-
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priately selected young patients. Resurfacing implants demand
high manufacturing standards to produce consistently low wear
bearings. The background research and better understanding of
implant failure would suggest that hip resurfacing technology has
now developed beyond that of an experimental procedure. Only
long term results and experience with this technology in the wider
Orthopaedic community will give the answer as to whether the
results will be durable, or if hip resurfacing will simply become a
bone conserving intervention prior to conventional THR.
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MINIMAL INVASIVE HIP SURGERY: FICTION OR
REALITY?
Guenther Klaus
Developmental dysplasia of the hip, femoroacetabular impinge-
ment and advanced hip osteoarthritis are common disorders.
Numerous studies reinforce the improved pain and function after
conventional joint preserving treatment and/or joint replacement
surgery for these conditions.
With the introduction of innovative surgical techniques and instru-
ments new approaches have been developed, however, in order
to decrease morbidity and length of hospital stay. Arthroscopic
treatment of hip osteoarthritis, "minimal-invasive" hip replace-
ment and less invasive procedures in dysplasia or impingement
surgery are already of practical relevance.
Aim of the presentation is to inform about recent surgical de-
velopments and to discuss critically the potential advantages as
well as disadvantages of these new approaches.
In an increasing number of observational studies as well as
randomized trials the effects of minimal invasive techniques are
currently investigated. The clinical data base is not yet sufficient
to allow definite technology assessment, but – based on current
literature review as well as own experiences – first conclusions
can be drawn. Most articles, who have been published about less
invasive hip replacement, do not have a scientific quality high
enough to prove a substantial benefit. Few studies with an ap-
propriate level of evidence agree on reduced early postoperative
morbidity and improved function of patients after less invasive
surgical approaches, but complication rates and implant position
must be viewed with caution. There seems to be also a large
influence by the surgeon’s experience.
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REGULATORY ASPECTS OF IMPLEMENTING IMAGING
BIOMARKERS
Brad Wyman
Purpose: Many biomarkers extracted from imaging data have
been proposed and may potentially have an impact on the suc-
cessful development of disease modifying osteoarthritis drugs
(DMOAD) or as use as diagnostic tools. However, often the
focus of biomarker development, which usually originates in aca-
demic centers or small companies, is on the technology with
less consideration given to the regulatory aspects of implemen-
tation. This presentation will cover the regulatory issues required
for successful implementation of imaging biomarkers including
patient confidentiality protection, Good Clinical Practice (GCP),
Part 11 compliance, with an emphasis on design controls.
Description: The regulatory requirements for biomarkers will
be dependent on the use as a diagnostic or the trial specifica-
tions. An early phase DMOAD trial for internal decision making
has fewer requirements while a biomarker implemented as a
diagnostic device would have more stringent requirements.
The requirements protecting patient confidentiality vary in detail
between countries but in general prevent disclosing information,
such as name, that could readily identify the subject. This re-
quirement is universal for any clinical trial. Also, the principles of
GCP are expected to be followed by any phase of trial with more
scrutiny being required for registration trials.
Implementation of design controls is required for US and Eu-
ropean approval of any medical device. While implementation
of design controls is probably not required for biomarkers used
in DMOAD trials, the concepts, when properly implemented,
facilitates improved quality and operational success.
Since most of the imaging biomarkers have a significant soft-
ware component, the implementation of design controls will be
discussed in the context of software development. The most
common departure from proper software design is beginning the
process with coding. However, the key element to successful
software implementation is advanced planning prior to coding.
The first step is to establish a Quality System that defines the
processes for implementation at each phase. The next step is to
define and rigorously document the requirements in a software
requirements specification. Next are the detailed design of the
system including both the high-level architecture and the detailed
software component design. This is followed by implementation
or coding in conjunction with execution of a well documented
verification and validation plan. This systematically tests from
module level through system’s level. Each of these steps requires
proper documentation, review and traceability analysis to ensure
quality.
In the USA, studies that require handling of electronic records,
such as images, or involve computer systems invoke CFR Title
21 Part 11. The key aspects of this regulation are maintaining the
integrity and security of the data. This has greater implication for
registration trials, though the security is required for maintaining
subject confidentiality.
Conclusions: Attention to the regulatory requirements is critical
to the successful implementation of imaging biomarkers in either
DMOAD trials or as diagnostics. Developing biomarker tools with
design controls can help to ensure quality which is valuable even
if not strictly required by regulatory agencies.
